Shares of ALK-Abelló A/S (OTC:AKBLF – Get Free Report) fell 5.2% during trading on Wednesday . The stock traded as low as $25.13 and last traded at $25.13. 1 shares traded hands during mid-day trading, a decline of 100% from the average session volume of 670 shares. The stock had previously closed at $26.50.
ALK-Abelló A/S Price Performance
The business has a 50-day simple moving average of $24.05 and a two-hundred day simple moving average of $21.84.
About ALK-Abelló A/S
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food.
Recommended Stories
- Five stocks we like better than ALK-Abelló A/S
- Ride Out The Recession With These Dividend Kings
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- How to Start Investing in Real Estate
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- Top Stocks Investing in 5G Technology
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for ALK-Abelló A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALK-Abelló A/S and related companies with MarketBeat.com's FREE daily email newsletter.
